Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
Abstract
Methods are disclosed for predicting the efficacy of a drug for treating an inflammatory disease in a human patient, including: obtaining a sample of cells from the patient; obtaining a gene expression profile of the sample in the absence and presence of in vitro modulation of the cells with specific cytokines and/or mediators; and comparing the gene expression profile of the sample with a reference gene expression profile, wherein similarities between the sample expression profile and the reference expression profile predicts the efficacy of the drug for treating the inflammatory disease in the patient.
Claims
exact text as granted — not AI-modified1 . An expression profile comprising expression levels of gene products from one or more genes described in Tables 1, 2A, 2B, 4A, 4B and 5A-5E.
2 . The expression profile of claim 1 , wherein the expression profile comprises about 5 informative genes.
3 . The expression profile of claim 1 , wherein the expression profile comprises about 5 to about 100 informative genes.
4 . The expression profile of claim 1 , wherein the informative genes exhibit the greatest degree of differential expression between responders and non-responders.Join the waitlist — get patent alerts
Track US2007054309A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.